drugset / Trial / NCT04119102
Duobrii in Combination With Biologics
Phase 4
Recruiting
25 enrolled
Psoriasis Treatment Center of Central New Jersey
Ortho Dermatologics · collab
NaSingle-groupOpen-labelTreatment
Summary
12 weeks DUOBRII to patients with 2%-10% BSA who are receiving biologic therapy for at least 24 weeks
Timeline
- Start
- 2019-10-14
- Primary completion
- 2020-08-01
- Completion
- 2020-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Duobrii | Unknown | — | — |